We are live on ! Find out more
AI

Atria Investments Portfolio holdings

AUM $9.98B
1-Year Est. Return 26.5%
This Fund
S&P 500
This Quarter Est. Return
+3.79%
1 Year Est. Return
+26.5%
3 Year Est. Return
+76.3%
5 Year Est. Return
+88.62%
10 Year Est. Return
+324.13%
AUM
$2.68B
AUM Growth
+$318M
Cap. Flow
+$226M
Cap. Flow %
8.41%
Top 10 Hldgs %
24.68%
Holding
1,126
New
209
Increased
451
Reduced
292
Closed
169

Sector Composition

Rank Sector Weight
1 Technology 6.93%
2 Financials 4.65%
3 Healthcare 4.03%
4 Consumer Discretionary 3.96%
5 Industrials 3.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VRNS icon
701
Varonis Systems
VRNS
$5B
$340K 0.01%
14,571
+1,467
+11% +$31.5K
VSS icon
702
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$11.9B
$340K 0.01%
3,448
-2,587
-43% -$270K
CCL icon
703
Carnival Corporation Ltd
CCL
$39.7B
$339K 0.01%
7,508
+1,144
+18% +$59.9K
JKHY icon
704
Jack Henry & Associates
JKHY
$11.1B
$339K 0.01%
2,453
+474
+24% +$65.5K
OEF icon
705
iShares S&P 100 ETF
OEF
$20.6B
$336K 0.01%
+2,629
New +$336K
FSV icon
706
FirstService
FSV
$6.32B
$335K 0.01%
+3,216
New +$291K
ITA icon
707
iShares US Aerospace & Defense ETF
ITA
$14.7B
$335K 0.01%
3,180
-1,278
-29% -$132K
VVR icon
708
Invesco Senior Income Trust
VVR
$454M
$335K 0.01%
80,627
+3,996
+5% +$17.1K
CMP icon
709
Compass Minerals
CMP
$1.15B
$331K 0.01%
6,606
+218
+3% +$12K
GIB icon
710
CGI
GIB
$15.5B
$331K 0.01%
4,330
-1,941
-31% -$141K
NOBL icon
711
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
$12B
$331K 0.01%
+9,728
New +$331K
SAGE
712
DELISTED
Sage Therapeutics
SAGE
$331K 0.01%
2,025
-14
-0.7% -$2.39K
SRPT icon
713
Sarepta Therapeutics
SRPT
$1.77B
$327K 0.01%
2,629
-260
-9% -$31.6K
CHRW icon
714
C.H. Robinson
CHRW
$17.5B
$326K 0.01%
3,891
+45
+1% +$3.79K
PXD
715
DELISTED
Pioneer Natural Resource Co.
PXD
$326K 0.01%
2,628
+541
+26% +$83K
PH icon
716
Parker-Hannifin
PH
$135B
$323K 0.01%
2,003
+217
+12% +$37.4K
ZION icon
717
Zions Bancorporation
ZION
$10.3B
$323K 0.01%
8,031
-7,944
-50% -$368K
ZGNX
718
DELISTED
Zogenix, Inc.
ZGNX
$323K 0.01%
6,572
+1,332
+25% +$53.6K
IONS icon
719
Ionis Pharmaceuticals
IONS
$9.4B
$320K 0.01%
4,780
-1,852
-28% -$131K
SLB icon
720
SLB Ltd
SLB
$75B
$320K 0.01%
9,776
-3,907
-29% -$158K
SRE icon
721
Sempra
SRE
$54.8B
$319K 0.01%
+4,630
New +$304K
DD icon
722
DuPont de Nemours
DD
$19.2B
$317K 0.01%
3,777
-4,238
-53% -$506K
EPAM icon
723
EPAM Systems
EPAM
$5.09B
$317K 0.01%
+1,708
New +$294K
PODD icon
724
Insulet
PODD
$9.79B
$316K 0.01%
+2,108
New +$216K
BIL icon
725
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$46.9B
$315K 0.01%
3,440
-55,714
-94% -$5.1M

Similar funds

Atria Investments's Q2 2019 Portfolio in Review

As of Q2 2019, Atria Investments held 1,126 positions worth $2.68B, up 13% from $2.36B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Atria Investments deployed $226M of net new capital in Q2 2019, opening 209 new positions and adding to 451 existing holdings. Its largest new stake was Goldman Sachs Access Investment Grade Corporate Bond ETF: 960,343 shares worth $50.2M.

By sector, the portfolio is most concentrated in Technology at 6.9% of assets, up from 5.7% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Vanguard Total Bond Market, an estimated $55.7M trimmed.

  • Atria Investments's largest Q2 2019 buy was Goldman Sachs Access Investment Grade Corporate Bond ETF: 960,343 shares worth $50.2M.
  • Atria Investments added most to Vanguard Intermediate-Term Treasury ETF in Q2 2019, an estimated $50.6M increase.
  • Atria Investments's biggest Q2 2019 reduction was Vanguard Total Bond Market, cutting an estimated $55.7M.
  • Atria Investments fully exited Anadarko Petroleum in Q2 2019, selling an estimated $45.1M.
  • Atria Investments's ten largest holdings make up 25% of its $2.68B portfolio in Q2 2019.
  • Atria Investments opened 209 new positions and closed 169 in Q2 2019.
  • Atria Investments's portfolio value rose 13% quarter-over-quarter to $2.68B.

Based on Atria Investments's 13F filing for Q2 2019, filed 9 Aug 2019.